Company DescriptionMetabolon has quickly become a leader in the discovery of biomarkers using metabolomics. Located in Research Triangle Park, North Carolina, Metabolon is based in a biotechnology epicenter.

Proceeds PurposesProceeds will support the recent launch by Metabolon’s partner, Bostwick Laboratories, of Prostarix(TM), a urine-based test that provides important metabolic information on the likelihood that a patient with slightly elevated PSA scores has prostate cancer, thus confirming the need to proceed to biopsy. The funds will also be used for the continued development of Quantose(TM) IGT, Metabolon’s surrogate test for oral glucose tolerance, as well as its test for the recurrence of bladder cancer.